Skip to main content

Table 3 Summary of the dosimetric parameters from the investigated techniques of PTVs, OARs and MUs

From: A new strategy for volumetric-modulated arc therapy planning using AutoPlanning based multicriteria optimization for nasopharyngeal carcinoma

Item

Parameter

General MCO-VMAT

APMCO-VMAT

p value

PTV70

D98% (Gy)

69.5 ± 0.3

69.4 ± 0.5

0.66

 

D2% (Gy)

74.7 ± 0.9

74.9 ± 0.9

0.11

 

CN

0.6 ± 0.1

0.6 ± 0.1

0.50

PTV59.4

D98% (Gy)

58.1 ± 0.7

58.3 ± 0.7

0.09

 

D2% (Gy)

74.0 ± 0.6

74.1 ± 0.6

0.29

 

CN

0.5 ± 0.0

0.5 ± 0.1

0.89

PTV54

D98% (Gy)

53.2 ± 0.9

53.0 ± 0.8

0.31

 

D2% (Gy)

60.0 ± 0.9

60.1 ± 0.9

0.64

 

CN

0.2 ± 0.0

0.2 ± 0.0

0.15

Brainstem

D2% (Gy)

51.1 ± 2.1

50.9 ± 2.3

0.59

Spincal cord

D2% (Gy)

42.1 ± 1.8

41.8 ± 1.9

0.31

Left optic nerve

D2% (Gy)

46.2 ± 6.8

46.3 ± 7.0

0.74

Right optic nerve

D2% (Gy)

45.7 ± 7.4

45.2 ± 7.5

0.13

Chiasm

D2% (Gy)

41.8 ± 8.7

41.5 ± 9.4

0.67

Left len

D2% (Gy)

6.1 ± 1.0

6.1 ± 1.1

0.77

Right len

D2% (Gy)

6.1 ± 1.0

6.1 ± 1.1

0.93

Left parotid gland

V30 (%)

42.1 ± 5.6

42.7 ± 2.5

0.17

 

Dmean (Gy)

31.8 ± 1.7

31.2 ± 4.0

0.41

Right parotid gland

V30 (%)

42.5 ± 2.7

42.7 ± 2.9

0.24

 

Dmean (Gy)

31.2 ± 3.9

31.9 ± 1.7

0.16

Left temporal lobe

D2% (Gy)

63.2 ± 6.3

63.5 ± 6.7

0.34

Right temporal lobe

D2% (Gy)

64.5 ± 5.7

64.9 ± 5.7

0.36

Oral cavity (excluding PTV’s)

Dmean (Gy)

39.9 ± 2.7

39.7 ± 3.1

0.35

Glottic larynx

Dmean (Gy)

50.9 ± 3.3

45.6 ± 3.3

< 0.0001

Submandibular glands

Dmean (Gy)

55.1 ± 1.8

54.9 ± 2.1

0.55

Pharyngeal constrictor muscles

Dmean (Gy)

53.8 ± 1.4

49.3 ± 1.4

< 0.0001

MU

 

505.6 ± 40.5

510.5 ± 34.3

0.09

  1. Abbreviations: PTV planning target volume, D 98% dose to 98% of the structure, D 2% dose to 2% of the structure, CN conformation number, V 30 volume (%) of receiving 30 Gy, D mean mean dose, MU monitor unit
  2. Data are shown as mean values with one standard deviation